Zobrazeno 1 - 10
of 641
pro vyhledávání: '"Gerard J Nuovo"'
Autor:
Mohamed Omer, MD, MHA, MSc, Nicole Trepanowski, MD, Sara Yumeen, MD, Fatima N. Mirza, MD, MPH, Hayley S. Goldbach, MD, Deep Joshipura, MD, Sook-Bin Woo, DMD, Gerard J. Nuovo, MD, Leslie Robinson-Bostom, MD
Publikováno v:
JAAD Case Reports, Vol 42, Iss , Pp 52-55 (2023)
Externí odkaz:
https://doaj.org/article/8b10fb68e75a4fc2bf68213169360035
Autor:
Michela Garofalo, Young-Jun Jeon, Gerard J. Nuovo, Justin Middleton, Paola Secchiero, Pooja Joshi, Hansjuerg Alder, Natalya Nazaryan, Gianpiero Di Leva, Giulia Romano, Melissa Crawford, Patrick Nana-Sinkam, Carlo M. Croce
Publikováno v:
PLoS ONE, Vol 17, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/da59c71250ec495d913df7b1f0a30155
Autor:
Young-Jun Jeon, Taewan Kim, Dongju Park, Gerard J. Nuovo, Siyeon Rhee, Pooja Joshi, Bum-Kyu Lee, Johan Jeong, Sung-suk Suh, Jeff E. Grotzke, Sung-Hak Kim, Jieun Song, Hosung Sim, Yonghwan Kim, Yong Peng, Youngtae Jeong, Michela Garofalo, Nicola Zanesi, Jonghwan Kim, Guang Liang, Ichiro Nakano, Peter Cresswell, Patrick Nana-Sinkam, Ri Cui, Carlo M. Croce
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
TUSC3 resides on chromosome 8p which is frequently deleted in advanced stage tumors. Here, the authors show that TUSC3 loss mediated by miR-224/-520c promotes NSCLC metastasis where it enhances ATF-6α-dependent UPR and HRD-1 dependent ERAD, which in
Externí odkaz:
https://doaj.org/article/20aea16a00a84e518d6ba422033dbee0
Autor:
Marco Galasso, Carl Morrison, Linda Minotti, Fabio Corrà, Carlotta Zerbinati, Chiara Agnoletto, Federica Baldassari, Matteo Fassan, Armando Bartolazzi, Andrea Vecchione, Gerard J. Nuovo, Gianpiero Di Leva, Stefania D’Atri, Ester Alvino, Maurizio Previati, Brian J. Nickoloff, Carlo M. Croce, Stefano Volinia
Publikováno v:
Molecular Cancer, Vol 17, Iss 1, Pp 1-6 (2018)
Abstract Cutaneous melanoma (CM) is a malignancy with increasing occurrence. Its microRNA repertoire has been defined in a number studies, leading to candidates for biological and clinical relevance: miR-200a/b/c, miR-203, miR-205, miR-204, miR-211,
Externí odkaz:
https://doaj.org/article/276b897ea58a4f74b9ffb33c4fd15ed6
Autor:
Carol L. Wood
Publikováno v:
Journal of Nurse-Midwifery. 37:64-65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ab7d3d27201aebe78ed51b17f9685c7
https://doi.org/10.1016/0091-2182(92)90024-w
https://doi.org/10.1016/0091-2182(92)90024-w
Autor:
David C. Wilbur
Publikováno v:
Diagnostic Cytopathology. 13:362-362
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f56328f4baf9fee51f7a58dcfe931921
https://doi.org/10.1002/dc.2840130420
https://doi.org/10.1002/dc.2840130420
Autor:
Ben Pansky
Publikováno v:
Trends in Endocrinology and Metabolism. 6:256
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f36392d3df6fa8f128ca47a0a70c3adb
https://doi.org/10.1016/1043-2760(95)90045-4
https://doi.org/10.1016/1043-2760(95)90045-4
Autor:
Flavia Pichiorri, Craig C. Hofmeister, Balveen Kaur, Robert Baiocchi, John C. Byrd, Don M. Benson, Pearlly Yan, Alena Cristina Jaime-Ramirez, Matthew Old, Joseph Badway, Emily Smith, Alessandro Canella, Sarah Y. Schlotter, Xiaokui Mo, Gerard J. Nuovo, Douglas W. Sborov, Enrico Caserta, Andrew Stiff
Supplementary Fig. S1. Therapeutic efficacy of RV and HDACi against cancer B cells; Supplementary Fig. S2. HDACi increase JAM-1 expression without affecting cell viability; Supplementary Fig. S3. RV+HDACi display synergistic anti-myeloma activity; Su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::108dc400925926059cd6d97a1b4b5039
https://doi.org/10.1158/1535-7163.22508208.v1
https://doi.org/10.1158/1535-7163.22508208.v1
Autor:
Craig C. Hofmeister, Michael R. Grever, Flavia Pichiorri, Ashley E. Rosko, Yvonne A. Efebera, Don M. Benson, Gregory B. Lesinski, Thomas Mace, Andrew Stiff, Gerard J. Nuovo, Douglas W. Sborov
Supplementary table 1. Selected early phase clinical trials evaluating Reolysin single-agent and combination treatment regimens. Abbreviations: SD = stable disease, PR = partial response, CR = complete response; ER = endoplasmic reticulum.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::161226b48b79994fd93c3addfbb88ff5
https://doi.org/10.1158/1078-0432.22455674
https://doi.org/10.1158/1078-0432.22455674
Autor:
Craig C. Hofmeister, Michael R. Grever, Flavia Pichiorri, Ashley E. Rosko, Yvonne A. Efebera, Don M. Benson, Gregory B. Lesinski, Thomas Mace, Andrew Stiff, Gerard J. Nuovo, Douglas W. Sborov
supplemental legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b0821ff343d97e4b10a5dcf43780667
https://doi.org/10.1158/1078-0432.22455668.v1
https://doi.org/10.1158/1078-0432.22455668.v1